Skip to main content

$0.020 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
11 October 2024 at 3:16am
Register to track OVN and receive email alerts.

Oventus Medical Limited, a medical device company, engages in the development and commercialization of oral appliances for the treatment of obstructive sleep apnoea (OSA) and snoring in Australia, Canada, and the United States. The company offers O2Vent Optima, a 3D-printed nylon oral appliance for OSA patients; and ExVent, a valve accessory that fits into the open airway of the O2Vent Optima device. The company was incorporated in 2015 and is headquartered in Indooroopilly, Australia.

Expand Company Description

Market Cap (6-Jun)

$4,834,540 (1,655th)

Close (30-Jun)

$0.020

Volume (30-Jun)

0

Shortsold (3-Sep)

351 (0.00%) (554th)

52w High

$0.000

52w Low

$0.000

P/E

-

EPS

-0.05
Subject
OVN Ann: Market Update

OVN Ann: Market Update

OVN Ann: Market Update

OVN Ann: Market Update

OVN Ann: Appendix 3Z

OVN Ann: Resignation of Director

OVN Ann: Voluntary Administrators Report to Creditors

OVN Ann: Market Update

OVN Ann: Commencement of Canadian Distribution Agreement

OVN Ann: Creditor Update

OVN Ann: Initial Director's Interest Notice

OVN Ann: Director Appointment

OVN Ann: Market Update

OVN Ann: Creditor update

OVN Ann: Notification regarding unquoted securities - OVN

OVN Ann: Proposed issue of securities - OVN

OVN Ann: Market update

OVN Ann: Notification regarding unquoted securities - OVN

OVN Ann: Proposed issue of securities - OVN

OVN Ann: Suspension from Official Quotation - Annual Listing Fees

OVN Ann: Update - Appendix 4C for the Quarter ended 30 June 2022

OVN Ann: Deferral of Financial Reporting Obligations

OVN Ann: Extension of convening period for second creditor meeting

OVN Ann: Administrators' Update

OVN Ann: Oventus seeks Voluntary Administration to restructure

OVN Ann: Final Director's Interest Notice

OVN Ann: Voluntary Suspension

OVN Ann: Director Appointment/Resignation

OVN Ann: Trading Halt

OVN Ann: Oventus Q3 FY22 Quarterly Activity Report and Appendix 4C

OVN Ann: Notification regarding unquoted securities - OVN

OVN Ann: Notification of cessation of securities - OVN

OVN Ann: Notification of cessation of securities - OVN

OVN Ann: Oventus Investor Presentation

OVN Ann: Half Yearly Report and Accounts

OVN Ann: Oventus Investor Presentation

OVN Ann: Oventus online investor briefing invitation

OVN Ann: Oventus Q2 FY22 Quarterly Activity Report and Appendix 4C

OVN Ann: Oventus CEO Succession Plan

OVN Ann: R&D Tax Rebate received

OVN Ann: Notification of cessation of securities - OVN

OVN Ann: Notification regarding unquoted securities - OVN

OVN Ann: Notification of cessation of securities - OVN

OVN Ann: Notification of cessation of securities - OVN

OVN Ann: Jobkeeper Report

OVN Ann: Final Director's Interest Notice

OVN Ann: Results of Meeting

OVN Ann: AGM Presentation

OVN Ann: Chairman's Address to Shareholders

OVN Ann: Notification regarding unquoted securities - OVN

Register to track OVN and receive email alerts.

Similar Companies

AT1
COH
CSX
CYC
EMV
IBX
IPD
MX1
RSH
SOM